ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced that it recently held a Type B ...

ImmunityBio, Inc. (NASDAQ: IBRX) today announced an update on the status of enrollment in its randomized registrational trial ...

As concerns over global policy uncertainty reached a 20-year peak in 2025, BCG is warning that the issue must be a core ...

ImmunityBio (IBRX) stock jumps after the FDA meeting on the company's plans to seek label expansion for bladder cancer therapy Anktiva. Read more here.

The BCG compression tee sees me through every type of workout: 400-meter repeats, tempo runs, hill sprints, as well as ...

By default, metachronous bladder recurrences after UTUC surgery have been managed similarly to primary non-muscle invasive bladder cancer.

I was born and raised in India. On the day I was born, I am told I got my first jab, a vaccine called BCG (bacille Calmette-Guerin). Kids born in India today still get this vaccine. This century-old ...

Enrollment Progress in QUILT-2.005 The QUILT-2.005 trial aims to evaluate the efficacy of ANKTIVA® in conjunction with BCG in patients who have not previously received BCG treatment. As of January ...

BCG notes that shopping has become the third most common use case for GenAI, extending beyond big-ticket items to everyday ...